FDAnews Drug Daily Bulletin

CAMBREX AND CYTORI FORM STEM CELL PARTNERSHIP

June 19, 2006
A A

Cambrex Corporation and Cytori Therapeutics have entered into a strategic marketing agreement to provide adipose-derived stem cell products globally for use in basic and translational bioresearch. Pharmaceutical Business Review (http://www.pharmaceutical-business-review.com/article_news.asp?guid=7968E126-9D15-4E35-BABC-8E619B609381)